![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
B-Independent Regulation of Macrophage Function by Adenosine
Departments of Surgery (Z.H.N., E.A.D., C.S., G.H.) and Cell Biology and Molecular Medicine (S.J.L.), University of Medicine and Dentistry-New Jersey Medical School, Newark, New Jersey; Department of Pharmacology (E.S.V., G.H.), Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary; and Institute of Human Physiology and Clinical Experimental Research (C.S.), Semmelweis University of Medicine, Budapest, Hungary
Adenosine is released into the extracellular space from nerve terminals and
cells subjected to ischemic stress. This nucleoside modulates a plethora of
cellular functions via occupancy of specific receptors. Adenosine is also an
important endogenous regulator of macrophage function, because it suppresses
the production of a number of proinflammatory cytokines by these cells.
However, the mechanisms of this anti-inflammatory effect have not been well
characterized. We hypothesized that adenosine may exert some of its
anti-inflammatory effects by decreasing activation of the transcription factor
nuclear factor-
B (NF-
B), because gene expression of most of the
proinflammatory cytokines inhibited by adenosine is dependent on NF-
B
activation. Using bacterial lipopolysaccharide (LPS)-stimulated RAW 264.7
macrophages, we found that adenosine as well as adenosine receptor agonists
decreased the production of tumor necrosis factor (TNF)-
, a typical
NF-
B-regulated cytokine. This effect of adenosine was not due to an
action on the process of TNF-
release, because adenosine suppressed
also the intracellular levels of TNF-
. However, cDNA microarray
analysis revealed that mRNA levels of neither TNF-
nor other cytokines
were altered by adenosine in either LPS-activated or quiescent macrophages. In
addition, although LPS induced expression of a number of other, noncytokine
genes, including the adenosine A2b receptor, adenosine did not affect the
expression of these genes. Furthermore, adenosine as well as adenosine
receptor agonists failed to decrease LPS-induced NF-
B DNA binding,
NF-
B promoter activity, p65 nuclear translocation, and inhibitory
B degradation. Together, our results suggest that the anti-inflammatory
effects of adenosine are independent of NF-
B.
Address correspondence to: Dr. György Haskó, Department of Surgery, University of Medicine and Dentistry-New Jersey Medical School, 185 South Orange Ave., University Heights, Newark, NJ 07103. E-mail: haskoge{at}umdnj.edu
This article has been cited by other articles:
![]() |
G. Hasko and P. Pacher A2A receptors in inflammation and injury: lessons learned from transgenic animals J. Leukoc. Biol., March 1, 2008; 83(3): 447 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Macedo, G. Pinhal-Enfield, V. Alshits, G. Elson, B. N. Cronstein, and S. J. Leibovich Wound Healing Is Impaired in MyD88-Deficient Mice: A Role for MyD88 in the Regulation of Wound Healing by Adenosine A2A Receptors Am. J. Pathol., December 1, 2007; 171(6): 1774 - 1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Csoka, Z. H. Nemeth, L. Virag, P. Gergely, S. J. Leibovich, P. Pacher, C.-X. Sun, M. R. Blackburn, E. S. Vizi, E. A. Deitch, et al. A2A adenosine receptors and C/EBP{beta} are crucially required for IL-10 production by macrophages exposed to Escherichia coli Blood, October 1, 2007; 110(7): 2685 - 2695. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Haschemi, O. Wagner, R. Marculescu, B. Wegiel, S. C. Robson, N. Gagliani, D. Gallo, J.-F. Chen, F. H. Bach, and L. E. Otterbein Cross-Regulation of Carbon Monoxide and the Adenosine A2a Receptor in Macrophages J. Immunol., May 1, 2007; 178(9): 5921 - 5929. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Morello, K. Ito, S. Yamamura, K.-Y. Lee, E. Jazrawi, P. DeSouza, P. Barnes, C. Cicala, and I. M. Adcock IL-1beta and TNF-{alpha} Regulation of the Adenosine Receptor (A2A) Expression: Differential Requirement for NF-{kappa}B Binding to the Proximal Promoter J. Immunol., November 15, 2006; 177(10): 7173 - 7183. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Cavalcante, M. V. Castro, A. R. F. Barreto, G. W. Sullivan, M. Vale, P. R. C. Almeida, J. Linden, J. M. Rieger, F. Q. Cunha, R. L. Guerrant, et al. Effect of Novel A2A Adenosine Receptor Agonist ATL 313 on Clostridium difficile Toxin A-Induced Murine Ileal Enteritis. Infect. Immun., May 1, 2006; 74(5): 2606 - 2612. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. H. Nemeth, B. Csoka, J. Wilmanski, D. Xu, Q. Lu, C. Ledent, E. A. Deitch, P. Pacher, Z. Spolarics, and G. Hasko Adenosine A2A Receptor Inactivation Increases Survival in Polymicrobial Sepsis J. Immunol., May 1, 2006; 176(9): 5616 - 5626. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Martin, S. C. Pingle, D. M. Hallam, L. P. Rybak, and V. Ramkumar Activation of the Adenosine A3 Receptor in RAW 264.7 Cells Inhibits Lipopolysaccharide-Stimulated Tumor Necrosis Factor-{alpha} Release by Reducing Calcium-Dependent Activation of Nuclear Factor-{kappa}B and Extracellular Signal-Regulated Kinase 1/2 J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 71 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. H. Nemeth, C. S. Lutz, B. Csoka, E. A. Deitch, S. J. Leibovich, W. C. Gause, M. Tone, P. Pacher, E. S. Vizi, and G. Hasko Adenosine Augments IL-10 Production by Macrophages through an A2B Receptor-Mediated Posttranscriptional Mechanism J. Immunol., December 15, 2005; 175(12): 8260 - 8270. [Abstract] [Full Text] [PDF] |
||||